M Dougados

Active 1992–2015

Also published as
M. Dougados
50
Papers
23,903
Citations
50
h-index
50
i10-index

Citations

Citations per year for M Dougados1987: 3 citations1988: 1 citations1993: 1 citations1994: 3 citations1995: 6 citations1996: 4 citations1997: 4 citations1998: 17 citations1999: 19 citations2000: 29 citations2001: 43 citations2002: 53 citations2003: 72 citations2004: 147 citations2005: 177 citations2006: 222 citations2007: 220 citations2008: 210 citations2009: 200 citations2010: 242 citations2011: 262 citations2012: 232 citations2013: 227 citations2014: 202 citations2015: 250 citations2016: 175 citations2017: 149 citations2018: 122 citations2019: 569 citations2020: 599 citations2021: 419 citations2022: 306 citations2023: 184 citations2024: 365 citations2025: 142 citations2026: 3 citations1989–1992: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,594 citing papers, 16.2% of this breakdownUnited Kingdom: 920 citing papers, 9.4% of this breakdownNetherlands: 660 citing papers, 6.7% of this breakdownGermany: 611 citing papers, 6.2% of this breakdownFrance: 566 citing papers, 5.8% of this breakdownCanada: 495 citing papers, 5% of this breakdownItaly: 439 citing papers, 4.5% of this breakdownChina: 435 citing papers, 4.4% of this breakdownAustralia: 337 citing papers, 3.4% of this breakdownSpain: 333 citing papers, 3.4% of this breakdownBelgium: 278 citing papers, 2.8% of this breakdownJapan: 266 citing papers, 2.7% of this breakdown
0%16.2%Other 29.5%

Fields

  • Medicine87.2%
  • Biochemistry, Genetics and Molecular Biology5.1%
  • Immunology and Microbiology3%
  • Health Professions1%
  • Neuroscience0.7%
  • Engineering0.5%
  • Other2.5%

Topics

  • Rheumatoid Arthritis Research and Therapies15.6%
  • Osteoarthritis Treatment and Mechanisms9.1%
  • Spondyloarthritis Studies and Treatments8.2%
  • Total Knee Arthroplasty Outcomes4.3%
  • Systemic Lupus Erythematosus Research3.7%
  • Autoimmune and Inflammatory Disorders Research3.5%
  • Other55.6%

Coauthors

All papers

Open in search
  1. 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , P. P. Tak, Katherine S. Upchurch, Jiří Vencovský, Fred Wolfe, Gillian Hawker - Annals of the Rheumatic Diseases 2010 cited by 4,875

  2. Treating rheumatoid arthritis to target: recommendations of an international task force

    Authors: , , , , , , , , , , , , , , , , , , , , , - Annals of the Rheumatic Diseases 2010 cited by 2,097

  3. Evaluation of clinically relevant changes in patient reported outcomes in knee and hip osteoarthritis: the minimal clinically important improvement

    Authors: , , , , , , , , , , - Annals of the Rheumatic Diseases 2004 cited by 1,096

  4. OMERACT-OARSI Initiative: Osteoarthritis Research Society International set of responder criteria for osteoarthritis clinical trials revisited.

    Authors: , , , , , , , , , - Osteoarthritis and Cartilage 2004 cited by 854

  5. Evaluation of clinically relevant states in patient reported outcomes in knee and hip osteoarthritis: the patient acceptable symptom state

    Authors: , , , , , , , , , , - Annals of the Rheumatic Diseases 2004 cited by 630

  6. EULAR Recommendations 2003: an evidence based approach to the management of knee osteoarthritis: Report of a Task Force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT)

    Authors: , , , , , , , , , , , , , , , , , , , , , , - Annals of the Rheumatic Diseases 2003 cited by 2,051

  7. Assessment of enthesitis in ankylosing spondylitis

    Authors: , , , , , , , - Annals of the Rheumatic Diseases 2003 cited by 682

  8. Prevalence and characteristics of uveitis in the spondyloarthropathies: a systematic literature review

    Authors: , , - Annals of the Rheumatic Diseases 2007 cited by 364

  9. Recommendations for a core set of outcome measures for future phase III clinical trials in knee, hip, and hand osteoarthritis. Consensus development at OMERACT III.

    Authors: , , , , , , , , , - 1997 cited by 745

  10. ASAS/EULAR recommendations for the management of ankylosing spondylitis

    Authors: , , , , , , , , , , , , , , , , , , , , , - Annals of the Rheumatic Diseases 2005 cited by 704

  11. Risk of serious infections during rituximab, abatacept and anakinra treatments for rheumatoid arthritis: meta-analyses of randomised placebo-controlled trials

    Authors: , , - Annals of the Rheumatic Diseases 2008 cited by 476

  12. Impact of T-cell costimulation modulation in patients with undifferentiated inflammatory arthritis or very early rheumatoid arthritis: a clinical and imaging study of abatacept (the ADJUST trial)

    Authors: , , , , , , , , , , , - Annals of the Rheumatic Diseases 2009 cited by 257

  13. EULAR report on the use of ultrasonography in painful knee osteoarthritis. Part 1: Prevalence of inflammation in osteoarthritis

    Authors: , , , , , , , , , , , , , , , - Annals of the Rheumatic Diseases 2005 cited by 289

  14. Ankylosing spondylitis assessment group preliminary definition of short-term improvement in ankylosing spondylitis

    Authors: , , , , - Arthritis & Rheumatism 2001 cited by 610

  15. Design and conduct of clinical trials in patients with osteoarthritis: Recommendations from a task force of the Osteoarthritis Research Society

    Authors: , , , , , , , , , , , , , , - Osteoarthritis and Cartilage 1996 cited by 574

  16. High molecular weight sodium hyaluronate (hyalectin) in osteoarthritis of the knee: a 1 year placebo-controlled trial

    Authors: , , , - Osteoarthritis and Cartilage 1993 cited by 290

  17. Evidence for treating rheumatoid arthritis to target: results of a systematic literature search

    Authors: , , , , , , , , , , , , , , , , , , , - Annals of the Rheumatic Diseases 2010 cited by 256

  18. Sustained durability and tolerability of etanercept in ankylosing spondylitis for 96 weeks

    Authors: , , , , , , , , , , - Annals of the Rheumatic Diseases 2005 cited by 190

  19. Evaluation of the symptomatic and structural efficacy of a new hyaluronic acid compound, NRD101, in comparison with diacerein and placebo in a 1 year randomised controlled study in symptomatic knee osteoarthritis

    Authors: , , , , , - Annals of the Rheumatic Diseases 2004 cited by 125

  20. Early referral recommendation for newly diagnosed rheumatoid arthritis: evidence based development of a clinical guide

    Authors: , , , , , - Annals of the Rheumatic Diseases 2002 cited by 444

  21. Tolerance and short term efficacy of rituximab in 43 patients with systemic autoimmune diseases

    Authors: , , , , , , , , , , , , , , , , , , , , , - Annals of the Rheumatic Diseases 2004 cited by 399

  22. ASAS recommendations for collecting, analysing and reporting NSAID intake in clinical trials/epidemiological studies in axial spondyloarthritis

    Authors: , , , , , , - Annals of the Rheumatic Diseases 2010 cited by 245

  23. Efficacy and safety of steroid injections for shoulder and elbow tendonitis: a meta-analysis of randomised controlled trials

    Authors: , , - Annals of the Rheumatic Diseases 2008 cited by 199

  24. HLA-B27 positive patients differ from HLA-B27 negative patients in clinical presentation and imaging: results from the DESIR cohort of patients with recent onset axial spondyloarthritis

    Authors: , , , , - Annals of the Rheumatic Diseases 2011 cited by 158